-
Former Arsenal, Spain midfielder Cazorla retires
-
Spain, Portugal eye World Cup last 16
-
German drone maker raises $1.2 bn as investors pile into defence
-
Russian strikes kill 17 in biggest ever attack on Kyiv, mayor says
-
French scramble to find air conditioners before next heatwave
-
Uruguay veteran Cavani quits Boca Juniors
-
Japan deploys bear cameras in moutains as attacks surge
-
West Ham's Fernandes joins Spurs
-
Germany's Infineon opens major chip plant as EU seeks tech autonomy
-
Bones of contention: More research needed on 'd'Artagnan corpse'
-
Biggest ever Russian barrage on Kyiv kills at least 13
-
Coffee with a view: tourists flock to Starbucks overlooking North Korea
-
EU top court upholds record 4.1 bn euro Google fine
-
German coalition agrees on reform package in key breakthrough
-
Italy name two debutants to face Japan in Nations Championship opener
-
France recall record try scorer Penaud for All Blacks Test
-
Wallabies' Schmidt rules out another coaching job
-
Seoul's Kospi tanks as Asia tech firms suffer another blow
-
India asks Meta to hold WhatsApp username rollout over fraud fears
-
'Outstanding' Love to start at fly-half for All Blacks against France
-
Deadly Russian barrage on Kyiv kills at least 13
-
Campbell back from four years in Wallabies wilderness to face Ireland
-
Next indirect US-Iran talks after Khamenei funeral: mediators
-
Migrants pick up pieces back home after fleeing South Africa
-
Reviving Montenegro's 'ancient' olive tree
-
Farrell names Leinster-heavy Ireland side to face Wallabies
-
Resource rich PNG leaving its Pacific people behind: World Bank
-
Fearing Russian strike, Kyiv's Holodomor museum evacuates exhibits
-
Papal envoy presides over first Vietnam beatification rite
-
Germany's energy-hungry small firms struggle with green shift
-
LeBron James praises Balogun after 'Silencer' celebration
-
Pochettino says Balogun foul 'never' a red card as suspension looms
-
Farrell names Leinster-heavy side to face Wallabies
-
Campbell back after four years in Wallabies team to face Ireland
-
Most Asia markets down as tech firms take fresh blow
-
Kane saves England as USA, Belgium reach last 16
-
South Korean school baseball team suspended over 'Tank Day' chants
-
Budding chefs cook up new career at China's BBQ academy
-
Ceuzany, Cape Verde's golden voice with volcanic emotion
-
One stitch at a time: Artist's mission to recreate the Bayeux Tapestry
-
Balogun scores and sees red as US beat Bosnia 2-0
-
Deadly Russian barrage pounds Ukraine capital
-
EU top court to rule on record 4.1 bn euro Google fine
-
Belgium coach salutes Tielemans after World Cup rescue act
-
'Job forever': trade schools are all the rage in the AI era
-
Cracking open a can of cannabis -- America's new pastime (for now)
-
Celtics reportedly trading Brown to Sixers in NBA blockbuster
-
Russia strikes Ukraine capital with missiles and drones, wounds five
-
IRS Form 2290 Filing Window Now Open for 2026-27 Tax Period; Stay HVUT Compliant with EZ2290
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 02
Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing
Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions
Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions
JERSEY CITY, NJ / ACCESS Newswire / September 16, 2025 / Apprentice.io, the creator of the first AI-powered manufacturing platform for life sciences, today announced a strategic partnership with Aprecia, the industry leader in pharmaceutical three-dimensional printing (3DP). This collaboration marks a significant step forward in digitally connected drug manufacturing, combining cutting-edge AI technology with breakthrough 3DP innovation in drug delivery.
Through this partnership, Aprecia will implement Apprentice.io's intelligent manufacturing platform at its Ohio facility to accelerate production workflows designed to ensure consistent, reliable execution at scale. The integration will support Aprecia's mission to revolutionize how medications are produced and delivered using advanced additive manufacturing.
Apprentice's cloud-native platform delivers intuitive digital manufacturing capabilities and no-code integration tools that provide flexibility, scalability, and connectivity appropriate for Aprecia's manufacturing model. As Aprecia continues to grow, this technology foundation will enable rapid deployment and seamless scaling across multiple production sites.
"I believe that Aprecia is the next generation of additive manufacturing," said Angelo Stracquatanio, CEO & Co-founder of Apprentice.io. "They are at the absolute forefront of innovation in life sciences. Combined with our AI native approach to manufacturing, I am looking forward to seeing what we can accomplish in the future."
Aprecia's deployment of Apprentice's technology reflects a shared commitment for next level pharmaceutical manufacturing. The collaboration underscores the industry's rapid evolution toward more sophisticated, data-driven manufacturing approaches that can adapt to and scale complex formulation requirements while maintaining the highest quality standards.
"Aprecia is leading the way in pharmaceutical 3D printing, driven by a commitment to transform patient care through innovation, said Kyle Smith, president and chief operating officer at Aprecia. Our partnership with Apprentice.io strengthens that mission, leveraging AI-powered solutions to scale precision drug delivery and redefine what's possible in oral medication. We will continue to integrate cutting-edge technologies that keep us at the forefront and address the evolving needs of patients and caregivers."
About Aprecia
Aprecia has brought significant change to pharmaceutical manufacturing with advanced 3D printing technology, enhancing the speed, flexibility, and precision of oral medication production. Through strategic partnerships, Aprecia can create personalized medicine and accelerate market entry, setting new standards in the industry.
Located in Mason, Ohio, Aprecia's capabilities include pharmaceutical manufacturing, drug product development, engineering innovation, and analytical methods. For over 20 years, Aprecia has led in pharmaceutical additive manufacturing technologies, establishing 3D printing as a viable pharmaceutical manufacturing option and is continuously exploring ways to improve medicine and patient health outcomes. For more information, visit www.aprecia.com.
About Apprentice
Apprentice is the industry's first agentic manufacturing platform built for a world beyond paper and legacy MES. Apprentice unifies MES, LES, automation, and remote collaboration capabilities together in a modern, no-code platform while simultaneously deploying AI Agents to support every step of manufacturing. The AI Agents operate autonomously to amplify human efforts, optimize processes, and scale throughput while reducing costs. The company's technology drives innovation at every stage-from design and creation to simulation, execution, and optimization. For over a decade, we've helped life sciences companies integrate their people, processes, and systems into a single next-gen platform. Today, Apprentice serves all manufacturing sectors fulfilling the vision of what a digital "Apprentice" can be. For more information, visit www.apprentice.io.
Contact Information:
Kristen Kucks
Director of Communications, Marketing
[email protected]
Justin Foreman
[email protected]
SOURCE: Apprentice.io
View the original press release on ACCESS Newswire
O.Brown--AT